Wenqi You
École Polytechnique Fédérale de Lausanne
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Wenqi You.
international conference of the ieee engineering in medicine and biology society | 2011
Wenqi You; Nicolas Widmer; Giovanni De Micheli
Machine learning has been largely applied to analyze data in various domains, but it is still new to personalized medicine, especially dose individualization. In this paper, we focus on the prediction of drug concentrations using Support Vector Machines (S VM) and the analysis of the influence of each feature to the prediction results. Our study shows that SVM-based approaches achieve similar prediction results compared with pharmacokinetic model. The two proposed example-based SVM methods demonstrate that the individual features help to increase the accuracy in the predictions of drug concentration with a reduced library of training data.
international conference of the ieee engineering in medicine and biology society | 2013
Wenqi You; Alena Simalatsar; Giovanni De Micheli
This paper proposes a parameterized Support Vector Machine (ParaSVM) approach for modeling the Drug Concentration to Time (DCT) curves. It combines the merits of Support Vector Machine (SVM) algorithm that considers various patient features and an analytical model that approximates the predicted DCT points and enables curve calibrations using occasional real Therapeutic Drug Monitoring (TDM) measurements. The RANSAC algorithm is applied to construct the parameter library for the relevant basis functions. We show an example of using ParaSVM to build DCT curves and then calibrate them by TDM measurements on imatinib case study.
International Journal on Artificial Intelligence Tools | 2014
Alena Simalatsar; Wenqi You; Verena Gotta; Nicolas Widmer; Giovanni De Micheli
Nowadays medical software is tightly coupled with medical devices that perform patient state monitoring and lately even some basic treatment procedures. Medical guidelines (GLs) can be seen as specification of a medical system which requires their computer-interpretable representation of medical GLs. Until now most of the medical GLs are often represented in a textual format and therefore often suffer from such structural problems as incompleteness, inconsistencies, ambiguity and redundancy, which makes the translation process to the machine-interpretable language more complicated. Computer-based interpretation of GLs can improve the quality of protocols as well as the quality of medical service. Several GLs formal representation methods have been presented recently. Only some of them enable automatic formal verification by introducing an additional translation path to the existing model checking environments. However, if a verified property fails it is difficult to trace back the result needed to change the model. Moreover, these formalisms provide the notion of time mostly in terms of actions order. In this paper we preset the application of a well-know formal behaviour representation approach of embedded systems design domain to medical GLs interpretation. We use Timed Automata extended with Tasks (TAT) and TIMES toolbox to represent medical GLs as a system behaviour in a computer interpretable form. We discuss the verification issues with the help of the anticancer drug imatinib case study.
bioinformatics and bioengineering | 2014
Alena Simalatsar; Romain Bornet; Wenqi You; Yann Thoma; Giovanni De Micheli
Poor adherence to medical regimen causes approximately 33% to 69% of medication-related hospitalizations and accounts for
bioinformatics and biomedicine | 2012
Wenqi You; Alena Simalatsar; Nicolas Widmer; Giovanni De Micheli
100 billion in annual health care costs. In this paper we address the problem of unintentional non adherence, when patient fails to take a medication due to forgetfulness or carelessness. We present the safe approach to software implementation of a portable reminder device with enabled personalization of medical regimen. The presented prototype is designed for imatinib administration, a drug used to treat Chronic Myeloid Leukemia (CML). However, thanks to the component-based structure of the software, the method can be applied to other cases by replacing implementation of certain components.
Proceedings of the International Workshop on Innovative Simulation for Healthcare (IWISH) | 2012
Wenqi You; Alena Simalatsar; Giovanni De Micheli
biomedical engineering and informatics | 2011
Wenqi You; Nicolas Widmer; Giovanni De Micheli
Journal of Bionanoscience | 2013
Wenqi You; Alena Simalatsar; Nicolas Widmer; Giovanni De Micheli
Proceedings of the 7th Annual World Congress of Industrial Biotechnology (IBIO) | 2014
Giovanni De Micheli; Wenqi You; Nicolas Widmer; Alena Simalatsar
Archive | 2014
Alena Simalatsar; Wenqi You; Dechao Sun; Verena Gotta; Nicolas Widmer; Giovanni De Micheli